CATX Perspective Therapeutics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Perspective Therapeutics, Inc. (CATX) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 16, 2026, a 10-Q quarterly report filed on May 11, 2026, an 8-K current report filed on June 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Perspective Therapeutics, Inc. (CATX) (SEC CIK 728387), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Perspective Therapeutics, Inc. (CATX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jun 1, 2026 | — | — | |
8-K | May 27, 2026 | — | — | |
8-K | May 22, 2026 | — | — | |
10-Q | May 11, 2026 | Mar 31, 2026 | — | |
8-K | May 11, 2026 | — | — | |
8-K | May 4, 2026 | — | — | — |
8-K | Apr 20, 2026 | — | — | — |
8-K | Apr 1, 2026 | — | — | — |
8-K | Mar 16, 2026 | — | Analysis | — |
10-K | Mar 16, 2026 | Dec 31, 2025 | — | |
8-K | Feb 3, 2026 | — | — | |
8-K | Feb 2, 2026 | — | — | |
8-K | Jan 14, 2026 | — | — | |
8-K | Jan 12, 2026 | — | — | |
8-K | Jan 9, 2026 | — | — | |
8-K | Dec 1, 2025 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 13, 2025 | Jun 30, 2025 | — | |
10-Q | May 12, 2025 | Mar 31, 2025 | — | |
10-K | Mar 26, 2025 | Dec 31, 2024 | — | |
SC 13G | Nov 14, 2024 | — | — | |
SC 13G | Nov 14, 2024 | — | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
SC 13G | Nov 8, 2024 | — | — | |
SC 13G | Nov 7, 2024 | — | — |
Frequently Asked Questions
What are the latest CATX SEC filings in 2026?
Perspective Therapeutics, Inc. (CATX) has filed a 10-K annual report on March 16, 2026, a 10-Q quarterly report on May 11, 2026, an 8-K current report on June 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CATX file its most recent 10-K annual report?
Perspective Therapeutics, Inc. (CATX) filed its most recent 10-K annual report on March 16, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CATX 10-Q quarterly reports?
Perspective Therapeutics, Inc. (CATX)'s most recent 10-Q quarterly report was filed on May 11, 2026. SignalX displays every CATX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CATX filed recently?
Perspective Therapeutics, Inc. (CATX)'s most recent 8-K was filed on June 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CATX insider trading activity (Form 4)?
SignalX aggregates every CATX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CATX file with the SEC?
Perspective Therapeutics, Inc. (CATX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CATX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Perspective Therapeutics, Inc. (CATX).
What is CATX's SEC CIK number?
Perspective Therapeutics, Inc. (CATX)'s SEC CIK (Central Index Key) number is 728387. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 728387 to look up all CATX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CATX return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Perspective Therapeutics, Inc. (CATX) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Perspective Therapeutics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 102+ filings.